Predictors of time to biochemical recurrence in a radical prostatectomy cohort within the PSA-era

Authors

  • Ahva Shahabi Department of Preventive Medicine, Keck School of Medicine of USC
  • Raj Satkunasivam Department of Urology, USC Institute of Urology and Norris Comprehensive Cancer Center, Keck School of Medicine of USC
  • Inderbir S. Gill Department of Urology, USC Institute of Urology and Norris Comprehensive Cancer Center, Keck School of Medicine of USC
  • Gary Lieskovsky Department of Urology, USC Institute of Urology and Norris Comprehensive Cancer Center, Keck School of Medicine of USC
  • Sia Daneshmand Department of Urology, USC Institute of Urology and Norris Comprehensive Cancer Center, Keck School of Medicine of USC
  • Jacek K. Pinski Department of Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine of USC
  • Mariana C. Stern Department of Preventive Medicine, Keck School of Medicine of USC

DOI:

https://doi.org/10.5489/cuaj.3163

Abstract

Introduction: We sought to determine predictors for early and late biochemical recurrence following radical prostatectomy among localized prostate cancer patients.

Methods: The study included localized prostate cancer patients treated with radical prostatectomy (RP) at the University of Southern California from 1988 to 2008. Competing risks regression models were used to determine risk factors associated with earlier or late biochemical recurrence, defined using the median time to biochemical recurrence in this population (2.9 years after radical prostatectomy).

Results: The cohort for this study included 2262 localized prostate cancer (pT2-3N0M0) patients who did not receive neoadjuvant or adjuvant therapies. Of these patients, 188 experienced biochemical recurrence and a subset continued to clinical recurrence, either within (n=19, 10%) or following (n=13, 7%) 2.9 years after RP. Multivariable stepwise competing risks analysis showed Gleason score ≥7, positive surgical margin status, and ≥pT3a stage to be associated with biochemical recurrence within 2.9 years following surgery. Predictors of biochemical recurrence after 2.9 years were Gleason score 7 (4+3), preoperative prostate-specific antigen (PSA) level, and ≥pT3a stage.

Conclusions: Higher stage was associated with biochemical recurrence at any time following radical prostatectomy. Particular attention may need to be made to patients with stage ≥pT3a, higher preoperative PSA, and Gleason 7 prostate cancer with primary high-grade patterns when considering longer followup after RP.

Downloads

Download data is not yet available.

Downloads

Published

2016-01-14

How to Cite

Shahabi, A., Satkunasivam, R., Gill, I. S., Lieskovsky, G., Daneshmand, S., Pinski, J. K., & Stern, M. C. (2016). Predictors of time to biochemical recurrence in a radical prostatectomy cohort within the PSA-era. Canadian Urological Association Journal, 10(1-2), E17–22. https://doi.org/10.5489/cuaj.3163

Issue

Vol. 10 No. 1-2 (2016): CUAJ January

Section

Original Research

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.